ArticleCurrent microbiology2026
Promoter Engineering of the Surfactin Operon Enhances Surfactin Production in the Environmental Strain Bacillus subtilis RI4914.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to enhance surfactin production in Bacillus subtilis by replacing the native promoter of the surfactin synthase operon (PsrfA) with the strong IPTG-inducible promoter Pgrac to address challenges in large-scale biosurfactant production. The engineered strain was developed through homologous recombination, creating an integration cassette fused via overlap extension PCR and transformed into B. subtilis RI4914. Surfactin yields were assessed via oil spreading and UPLC-MS. Results showed that surfactin synthesis in the modified strain was nearly absent without IPTG. With IPTG, however, production surged 8.4-fold compared to the wild type, reaching 4.8 g/L. Productivity and carbon source yield also improved 8-fold and 11-fold, respectively. This promoter engineering strategy significantly enhanced surfactin production, with the observed increase being consistent with the expected behavior of IPTG-inducible Pgrac systems in Bacillus subtilis, suggesting an effective regulatory response associated with the tested expression system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.